Lazard (LAZ) Competitors $50.37 +0.35 (+0.70%) Closing price 07/3/2025 03:30 PM EasternExtended Trading$50.33 -0.04 (-0.08%) As of 07/3/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock LAZ vs. AMP, EQH, EVR, GS, JEF, JHG, MC, MS, PIPR, and SFShould you be buying Lazard stock or one of its competitors? The main competitors of Lazard include Ameriprise Financial (AMP), Equitable (EQH), Evercore (EVR), The Goldman Sachs Group (GS), Jefferies Financial Group (JEF), Janus Henderson Group (JHG), Moelis & Company (MC), Morgan Stanley (MS), Piper Sandler Companies (PIPR), and Stifel Financial (SF). These companies are all part of the "finance" sector. Lazard vs. Its Competitors Ameriprise Financial Equitable Evercore The Goldman Sachs Group Jefferies Financial Group Janus Henderson Group Moelis & Company Morgan Stanley Piper Sandler Companies Stifel Financial Lazard (NYSE:LAZ) and Ameriprise Financial (NYSE:AMP) are both finance companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations, earnings and media sentiment. Do insiders and institutionals hold more shares of LAZ or AMP? 54.8% of Lazard shares are owned by institutional investors. Comparatively, 84.0% of Ameriprise Financial shares are owned by institutional investors. 3.9% of Lazard shares are owned by company insiders. Comparatively, 0.7% of Ameriprise Financial shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Do analysts recommend LAZ or AMP? Lazard presently has a consensus target price of $46.33, suggesting a potential downside of 8.01%. Ameriprise Financial has a consensus target price of $517.86, suggesting a potential downside of 4.64%. Given Ameriprise Financial's stronger consensus rating and higher possible upside, analysts plainly believe Ameriprise Financial is more favorable than Lazard.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lazard 2 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.86Ameriprise Financial 1 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.29 Which has preferable valuation and earnings, LAZ or AMP? Ameriprise Financial has higher revenue and earnings than Lazard. Lazard is trading at a lower price-to-earnings ratio than Ameriprise Financial, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLazard$3.05B1.86$279.91M$2.8717.55Ameriprise Financial$17.26B3.00$3.40B$29.4318.45 Does the media prefer LAZ or AMP? In the previous week, Ameriprise Financial had 13 more articles in the media than Lazard. MarketBeat recorded 34 mentions for Ameriprise Financial and 21 mentions for Lazard. Ameriprise Financial's average media sentiment score of 1.34 beat Lazard's score of 0.42 indicating that Ameriprise Financial is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lazard 4 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Neutral Ameriprise Financial 25 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is LAZ or AMP more profitable? Ameriprise Financial has a net margin of 17.14% compared to Lazard's net margin of 10.15%. Ameriprise Financial's return on equity of 68.93% beat Lazard's return on equity.Company Net Margins Return on Equity Return on Assets Lazard10.15% 37.64% 5.18% Ameriprise Financial 17.14%68.93%2.03% Which has more volatility & risk, LAZ or AMP? Lazard has a beta of 1.33, indicating that its stock price is 33% more volatile than the S&P 500. Comparatively, Ameriprise Financial has a beta of 1.23, indicating that its stock price is 23% more volatile than the S&P 500. Is LAZ or AMP a better dividend stock? Lazard pays an annual dividend of $2.00 per share and has a dividend yield of 4.0%. Ameriprise Financial pays an annual dividend of $6.40 per share and has a dividend yield of 1.2%. Lazard pays out 69.7% of its earnings in the form of a dividend. Ameriprise Financial pays out 21.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Ameriprise Financial has increased its dividend for 21 consecutive years. SummaryAmeriprise Financial beats Lazard on 15 of the 19 factors compared between the two stocks. Get Lazard News Delivered to You Automatically Sign up to receive the latest news and ratings for LAZ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LAZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LAZ vs. The Competition Export to ExcelMetricLazardFIN IndustryFinance SectorNYSE ExchangeMarket Cap$5.68B$7.65B$12.20B$20.70BDividend Yield3.97%4.75%5.53%3.71%P/E Ratio17.5518.1320.0528.10Price / Sales1.866.2426.0138.27Price / Cash7.7922.4521.7022.53Price / Book8.282.722.284.58Net Income$279.91M$304.38M$1.00B$985.54M7 Day Performance5.14%7.36%2.25%2.79%1 Month Performance12.32%10.94%3.69%4.37%1 Year Performance27.36%25.58%541.99%15.08% Lazard Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LAZLazard4.4172 of 5 stars$50.37+0.7%$46.33-8.0%+27.4%$5.68B$3.05B17.553,263Trending NewsAnalyst RevisionGap UpAMPAmeriprise Financial4.6061 of 5 stars$534.26+1.2%$519.00-2.9%+25.6%$50.87B$17.26B18.1513,500News CoveragePositive NewsAnalyst ForecastEQHEquitable4.4439 of 5 stars$56.11+0.3%$62.64+11.6%+37.7%$17.05B$12.44B15.258,000Positive NewsEVREvercore4.5278 of 5 stars$270.85+0.7%$250.57-7.5%+35.1%$10.60B$3.09B25.922,380GSThe Goldman Sachs Group4.8817 of 5 stars$708.51+2.6%$595.67-15.9%+56.0%$217.40B$126.85B16.4446,500Trending NewsAnalyst ForecastJEFJefferies Financial Group4.5799 of 5 stars$54.71-1.9%$66.00+20.6%+12.3%$11.28B$7.03B20.657,822Trending NewsJHGJanus Henderson Group4.2866 of 5 stars$38.88+0.4%$42.78+10.0%+18.2%$6.13B$2.54B15.432,300News CoverageAnalyst ForecastMCMoelis & Company2.5269 of 5 stars$62.45-0.8%$64.17+2.7%+13.3%$4.90B$1.19B28.651,309MSMorgan Stanley4.7029 of 5 stars$141.08+0.3%$133.62-5.3%+45.1%$226.34B$107.29B16.5680,000Trending NewsBuyback AnnouncementPIPRPiper Sandler CompaniesN/A$278.89-1.0%$286.00+2.5%N/A$4.96B$1.49B24.381,805Positive NewsHigh Trading VolumeSFStifel Financial4.4787 of 5 stars$103.98+0.3%$105.50+1.5%+32.4%$10.68B$4.97B19.889,000News CoveragePositive NewsAnalyst Downgrade Related Companies and Tools Related Companies AMP Competitors EQH Competitors EVR Competitors GS Competitors JEF Competitors JHG Competitors MC Competitors MS Competitors PIPR Competitors SF Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:LAZ) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 4th: 59% dividend from Bitcoin (No Crypto Needed)I've got something exciting for you this July 4th holiday... How about a 59.07% dividend from Bitcoin? Y...Investors Alley | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lazard, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lazard With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.